As of 2026-09-22, the Fair Value of Meridian Bioscience Inc (VIVO) is -3.81 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 3.86 USD, the upside of Meridian Bioscience Inc is -198.69%.
With the market price of 3.86 USD and our fair value calculation, Meridian Bioscience Inc (VIVO) is not a good investment. Investing in VIVO stocks now will result in a potential loss of 198.69%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | 5Y Avg | |
| Net income | -7.57 | -22.05 | -24.35 | -46.70 | -12.79 | -22.69 |
| YoY growth | -48.36% | -191.30% | -10.43% | -91.75% | 72.61% | -53.85% |
| Market Cap (mil) | 64.81 |
| P/E | |
| Forward P/E |
| EPS | -0.76 |
| Avg earnings growth rate | -53.85% |
| TTM earnings | -12.79 |